NEW YORK (GenomeWeb News) – Newly formed Selah Genomics today announced that it has acquired EnGenCore for an undisclosed amount.

Selah CEO Michael Bolick said in a statement that the purchase of EnGenCore will lead to the development of "molecular and genomic technology at [the University of South Carolina] with an eye toward helping translate this impactful technology to the clinic." The firm's Clinical Genomics Center is located at the GHS Institute for Translational Oncology Research in close proximity to the USC medical school, he noted.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.